An invasive zone in human liver cancer identified by Stereo-seq promotes hepatocyte–tumor cell crosstalk, local immunosuppression and tumor progression
2023 · Cell Research · 195 citations
https://doi.org/10.1038/s41422-023-00831-1
R
Rongkui Luo
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
155
Papers
1.5K
Citations
21
h-index
37
i10-index
Rongkui Luo is an academic researcher from Western University. The author has contributed to research in topics: Sarcoma Diagnosis and Treatment & Peptidase Inhibition and Analysis & Cancer Immunotherapy and Biomarkers. The author has an h-index of 21, co-authored 132 publications.
ORCID: 0000-0002-4118-7225Papers by this author
worksProteomic analysis reveals key differences between squamous cell carcinomas and adenocarcinomas across multiple tissues
2022 · Nature Communications · 30 citations
https://doi.org/10.1038/s41467-022-31719-0
Proteomic characterization identifies clinically relevant subgroups of soft tissue sarcoma
2024 · Nature Communications · 26 citations
https://doi.org/10.1038/s41467-024-45306-y
Mining the interpretable prognostic features from pathological image of intrahepatic cholangiocarcinoma using multi-modal deep learning
2024 · BMC Medicine · 19 citations
https://doi.org/10.1186/s12916-024-03482-0
IgG4-related systemic disease mimicking renal pelvic cancer: a rare case
2014 · World Journal of Surgical Oncology · 18 citations
https://doi.org/10.1186/1477-7819-12-395
Identifying <scp>HER2</scp> from serum‐derived exosomes in advanced gastric cancer as a promising biomarker for assessing tissue <scp>HER2</scp> status and predicting the efficacy of trastuzumab‐based therapy
2022 · Cancer Medicine · 17 citations
https://doi.org/10.1002/cam4.5269
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat